Kiniksa Pharmaceuticals Ltd(KNSA)— 同業公司組

數據截至2026-09-18 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Kiniksa Pharmaceuticals Ltd的Closelook綜合評分為56/100,在同業公司組內排名第7位(共11家)——組內評分最高的是DexCom Inc(66/100)。

名稱綜合動能品質估值訊號距52週高點
KNSA Kiniksa Pharmaceuticals Ltd56925819ok6.9%
ROVI.MC Laboratorios Farmaceuticos ROVI60207651info32.3%
LNTH Lantheus Holdings Inc60697558info10.1%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895742ok2.9%
BHC.TO Bausch Health Companies Inc54507083info28.5%
ALKS Alkermes Plc53665222info22.1%
ALM.MC Almirall S.A.52234466warn24.3%
DXCM DexCom Inc66868035bull5%
ARGX argenx NV ADR64797427ok7.7%
ONC BeiGene, Ltd.63756332ok8.9%
MEDP Medpace Holdings Inc63867429ok9.7%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板

FAQ · from the current data · as of 2026-09-18

Quick answers

Kiniksa Pharmaceuticals Ltd在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、Bausch Health Companies Inc (BHC.TO)、Alkermes Plc (ALKS)、Almirall S.A. (ALM.MC)、DexCom Inc (DXCM)、argenx NV ADR (ARGX)等。

KNSA相對同業公司的評分如何?

Kiniksa Pharmaceuticals Ltd的綜合評分為56/100,組內排名第7位(共11家),截至2026-09-18;組內最高綜合評分為DexCom Inc(66/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.